Vvmed is a specialist medical practice in Chaudfontaine. Private Limited, started on 4 November 2019, 1 establishment.

What is the address of Vvmed?

The registered office of Vvmed is located at Chemin du Tarbois 45, 4052 Chaudfontaine.

Is Vvmed still active?

Yes. According to the CBE (16 September 2026) Vvmed is active, legal situation “Normale toestand”, started on 4 November 2019.

Is Vvmed registered on Peppol?

Yes, Vvmed is registered on the Peppol network with ID 0208:0737385981.

What is the enterprise number of Vvmed?

The enterprise number of Vvmed is BE0737385981.

When was Vvmed founded?

Vvmed was founded on 4 November 2019.

Who are the directors of Vvmed?

According to the 2025 annual accounts, the directors of Vvmed are: Vanessa Verdin.

Is Vvmed a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 November 2019; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Vvmed make in 2025?

Vvmed posted a profit after taxes of € 189,171 in financial year 2025.

What is the revenue of Vvmed?

As a small company, Vvmed is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 326,280.

Vvmed (Private Limited) - Chaudfontaine - BE0737385981

Dossier Vvmed, printed on 16 September 2026 from databakkes.be/en/0737385981/vvmed. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Vvmed from Chaudfontaine, company number BE0737385981, closed financial year 2025 with a result of € 189,171 after tax. For that financial year Vvmed recorded a gross margin of € 326,280 and equity of € 143,671. Compared with financial year 2024, the result moved from € 93,624 to € 189,171. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on January 30, 2026.

What it is worth Growing

€ 143,671

▲ € 139,171 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 189,171

▲ 102% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 468,378

▲ 56% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 50,000 paid out

26 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 1,871

▼ 83% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 18,453

▼ 47% vs 2024

€ 10,208 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 11,078

▼ 15% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 41,917

▲ 188% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 123,606 Gross margin 2022: € 123,606 First fiscal year in the series	€ 177,317 Gross margin 2023: € 177,317 ▲ 43% vs 2022 (€ 123,606) Favourable step	€ 173,211 Gross margin 2024: € 173,211 ▼ 2% vs 2023 (€ 177,317) Unfavourable step	€ 326,280 Gross margin 2025: € 326,280 ▲ 88% vs 2024 (€ 173,211) Favourable step	▲ 88%
Profit after taxes	€ 79,479 Profit after taxes 2022: € 79,479 First fiscal year in the series	€ 93,742 Profit after taxes 2023: € 93,742 ▲ 18% vs 2022 (€ 79,479) Favourable step	€ 93,624 Profit after taxes 2024: € 93,624 Unchanged (€ 93,742) Unfavourable step	€ 189,171 Profit after taxes 2025: € 189,171 ▲ 102% vs 2024 (€ 93,624) Favourable step	▲ 102%
Equity	€ 241,459 Equity 2022: € 241,459 First fiscal year in the series	€ 4,500 Equity 2023: € 4,500 ▼ 98% vs 2022 (€ 241,459) Unfavourable step	€ 4,500 Equity 2024: € 4,500 Unchanged (€ 4,500) Unchanged	€ 143,671 Equity 2025: € 143,671 ▲ € 139,171 vs 2024 (€ 4,500) Favourable step	▲ € 139,171
Total debts	€ 73,668 Total debts 2022: € 73,668 First fiscal year in the series	€ 401,034 Total debts 2023: € 401,034 ▲ € 327,366 vs 2022 (€ 73,668) Unfavourable step	€ 472,129 Total debts 2024: € 472,129 ▲ 18% vs 2023 (€ 401,034) Unfavourable step	€ 507,551 Total debts 2025: € 507,551 ▲ 8% vs 2024 (€ 472,129) Unfavourable step	▲ 8%
Cash	€ 143,689 Cash 2022: € 143,689 First fiscal year in the series	€ 234,918 Cash 2023: € 234,918 ▲ 63% vs 2022 (€ 143,689) Favourable step	€ 299,925 Cash 2024: € 299,925 ▲ 28% vs 2023 (€ 234,918) Favourable step	€ 468,378 Cash 2025: € 468,378 ▲ 56% vs 2024 (€ 299,925) Favourable step	▲ 56%
Retained profit	€ 236,959 Retained profit 2022: € 236,959 First fiscal year in the series	€ 0 Retained profit 2023: € 0 ▼ 100% vs 2022 (€ 236,959) Unfavourable step	€ 0 Retained profit 2024: € 0 Unchanged (€ 0) Unchanged	€ 139,171 Retained profit 2025: € 139,171 Unchanged (€ 0) Favourable step
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 330,701 Dividend 2023: € 330,701 Unchanged (€ 0) Unchanged	€ 93,624 Dividend 2024: € 93,624 ▼ 72% vs 2023 (€ 330,701) Unchanged	€ 50,000 Dividend 2025: € 50,000 ▼ 47% vs 2024 (€ 93,624) Unchanged	▼ 47%
Bank debt	€ 66,883 Bank debt 2022: € 66,883 First fiscal year in the series	€ 50,909 Bank debt 2023: € 50,909 ▼ 24% vs 2022 (€ 66,883) Favourable step	€ 34,767 Bank debt 2024: € 34,767 ▼ 32% vs 2023 (€ 50,909) Favourable step	€ 18,453 Bank debt 2025: € 18,453 ▼ 47% vs 2024 (€ 34,767) Favourable step	▼ 47%
Balance sheet total	€ 315,127 Balance sheet total 2022: € 315,127 First fiscal year in the series	€ 405,534 Balance sheet total 2023: € 405,534 ▲ 29% vs 2022 (€ 315,127) Unchanged	€ 476,629 Balance sheet total 2024: € 476,629 ▲ 18% vs 2023 (€ 405,534) Unchanged	€ 651,222 Balance sheet total 2025: € 651,222 ▲ 37% vs 2024 (€ 476,629) Unchanged	▲ 37%

Key figures of Vvmed, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to Vvmed?

What happened at Vvmed in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 30, 2026 New annual accounts for financial year 2025: profit of € 189,171 (▲ 102% vs 2024). Source: NBB ↗
Nov 4, 2019 New establishment in Chaudfontaine. KBO
Nov 4, 2019 Start of the company according to the CBE. KBO

In short

From € 79,479 profit in 2022 to € 189,171 profit in 2025.

Paid € 109,678 in corporate taxes since 2022.

Best year ever: 2025, with € 189,171 profit.

Paid out € 474,325 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Vvmed? We notify you, reason included.

Follow Vvmed

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Vanessa Verdin

Vvmed

J.C.B.S.C.

Behind Vvmed is Vanessa Verdin. Vanessa Verdin is also behind J.C.B.S.C..

See the full network in the app

Directors

According to the 2025 annual accounts

Vanessa Verdin

Director

Also active at: J.C.B.S.C.

Establishments

Establishment units

Physical locations of this company

Registered office

Chemin du Tarbois 45

4052 Chaudfontaine

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0737.385.981
VAT number: BE 0737.385.981
Registered office: Chemin du Tarbois 45, 4052 Chaudfontaine
Names & denominations: Vvmed
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 4 November 2019
Peppol: Active · Active since 15 Jan 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗